(Q38031827)

27 August 2017

Redox control of NLRP3 inflammasome activation in health and disease (English)

1 reference

27 August 2017

1 reference

1

Anna Rubartelli

0 references

language of work or name

1 reference

2 August 2012

1 reference

Journal of Leukocyte Biology

27 August 2017

1 reference

27 August 2017

92

1 reference

27 August 2017

5

1 reference

27 August 2017

951-958

1 reference

A clinical perspective of IL-1β as the gatekeeper of inflammation

27 August 2017

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

A novel pathway for secretory proteins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

IL-1: discoveries, controversies and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Mechanisms of regulated unconventional protein secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

DAMPs, PAMPs and alarmins: all we need to know about danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Molecular cloning of the interleukin-1 beta converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Inflammasomes: current understanding and open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Regulation of inflammasome signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

A key role for redox signaling in rapid P2X7 receptor-induced IL-1 beta processing in human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Human NLRP3 inflammasome activation is Nox1-4 independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Free radicals in the physiological control of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

DAMPs and inflammatory processes: the role of redox in the different outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Pathogen-induced interleukin-1beta processing and secretion is regulated by a biphasic redox response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Redox remodeling allows and controls B-cell activation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Thioredoxin redox control of cell growth and death and the effects of inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Macrophage cell line RAW264.7 but not P-388D1 is an appropriate in vitro-model for studying oxidative burst as well as cytokine production in context of fatty acid enrichment

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

The rate of interleukin-1beta secretion in different myeloid cells varies with the extent of redox response to Toll-like receptor triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Interplay between redox status and inflammasome activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Thioredoxin reductase 1 haplotypes modify familial amyotrophic lateral sclerosis onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Active caspase-1 is a regulator of unconventional protein secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0512265

21 January 2018

Identifiers

DOI

10.1189/JLB.0512265

1 reference

27 August 2017

1 reference

PubMed ID

22859832